Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelley Zieroth

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Cardiac Failure Review|June 7, 2021
Hyperkalaemia in Heart FailureUmar Ismail, Kiran Sidhu, Shelley Zieroth
European Journal of Heart Failure|February 28, 2023
Sex differences in heart failure: the evolving use of biomarkersVanessa Blumer, Lauren K Truby, Shelley Zieroth
Journal of Cardiac Failure|October 5, 2024
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in "Negative" Clinical TrialsJessica R Overbey, Shelley Zieroth, Kert Viele
The Canadian Journal of Cardiology|July 5, 2017
Primary Percutaneous Coronary Intervention As Treatment for ST-Elevation Myocardial Infarction in a Centenarian: Choosing CarefullyJustin M Cloutier, Shelley Zieroth, Basem Elbarouni
Transplantation|December 11, 2012
Serum sickness after antithymocyte globulin administration in a cardiac transplant patientJacques Rizkallah, Francisco Cordova, Amrit Malik, et al.
European Heart Journal|January 23, 2025
The year in cardiovascular medicine 2024: the top 10 papers in heart failureJohann Bauersachs, Shelley Zieroth, Rudolf A de Boer
Current Opinion in Cardiology|January 13, 2017
End of life decisions in heart failure: to turn off the intracardiac device or not?Bilal Ayach, Amrit Malik, Colette Seifer, et al.
European Heart Journal|January 16, 2026
The year in cardiovascular medicine 2025: the top 10 papers in heart failureJohann Bauersachs, Shelley Zieroth, Rudolf A de Boer
European Heart Journal|January 19, 2024
The year in cardiovascular medicine 2023: the top 10 papers in heart failure and cardiomyopathiesJohann Bauersachs, Rudolf A de Boer, Shelley Zieroth
Journal of Cellular Physiology|April 5, 2013
Reversal of cardiac dysfunction and subcellular alterations by metoprolol in heart failure due to myocardial infarctionAndrea Babick, Vijayan Elimban, Shelley Zieroth, et al.
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Cardiac Failure Review|June 7, 2021
Hyperkalaemia in Heart FailureUmar Ismail, Kiran Sidhu, Shelley Zieroth
European Journal of Heart Failure|February 28, 2023
Sex differences in heart failure: the evolving use of biomarkersVanessa Blumer, Lauren K Truby, Shelley Zieroth
Journal of Cardiac Failure|October 5, 2024
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in "Negative" Clinical TrialsJessica R Overbey, Shelley Zieroth, Kert Viele
The Canadian Journal of Cardiology|July 5, 2017
Primary Percutaneous Coronary Intervention As Treatment for ST-Elevation Myocardial Infarction in a Centenarian: Choosing CarefullyJustin M Cloutier, Shelley Zieroth, Basem Elbarouni
Transplantation|December 11, 2012
Serum sickness after antithymocyte globulin administration in a cardiac transplant patientJacques Rizkallah, Francisco Cordova, Amrit Malik, et al.
European Heart Journal|January 23, 2025
The year in cardiovascular medicine 2024: the top 10 papers in heart failureJohann Bauersachs, Shelley Zieroth, Rudolf A de Boer
Current Opinion in Cardiology|January 13, 2017
End of life decisions in heart failure: to turn off the intracardiac device or not?Bilal Ayach, Amrit Malik, Colette Seifer, et al.
European Heart Journal|January 16, 2026
The year in cardiovascular medicine 2025: the top 10 papers in heart failureJohann Bauersachs, Shelley Zieroth, Rudolf A de Boer
European Heart Journal|January 19, 2024
The year in cardiovascular medicine 2023: the top 10 papers in heart failure and cardiomyopathiesJohann Bauersachs, Rudolf A de Boer, Shelley Zieroth
Journal of Cellular Physiology|April 5, 2013
Reversal of cardiac dysfunction and subcellular alterations by metoprolol in heart failure due to myocardial infarctionAndrea Babick, Vijayan Elimban, Shelley Zieroth, et al.
Pageof 18